Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.34 |
| ▸ | FABP4 | P15090 | 1/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.34 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19194305 | 0.92 | FABP3 (0.35) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL20025717 | 0.90 | FABP3 (0.34) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL20025727 | 0.90 | FABP3 (0.37) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL20025716 | 0.84 | FABP3 (0.37) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL19194683 | 0.84 | DAPK1 (0.33) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL27843854 | 0.80 | FABP4 (0.32) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL19194657 | 0.80 | DAPK1 (0.35) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL11783087 | 0.79 | FABP4 (0.32) | FABP3FABP4FABP5RPS6KA3 | |
| SCHEMBL83879 | 0.78 | FABP4 (0.36) | FABP3FABP4FABP5 | |
| SCHEMBL7121356 | 0.78 | FABP4 (0.37) | FABP3FABP4FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11245111-B2 | Stable positive side material for all-organic flow battery | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2022-02-08 | — | — | US | disclosed |
| US-20210119240-A1 | MATERIALS FOR HIGH-PERFORMANCE AQUEOUS ORGANIC REDOX FLOW BATTERIES | US DEPARTMENT OF ENERGY | 2021-04-22 | — | — | US | disclosed |
| US-10833345-B2 | Materials for high-performance aqueous organic redox flow batteries | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2020-11-10 | — | — | US | disclosed |
| US-20180097249-A1 | MATERIALS FOR HIGH-PERFORMANCE AQUEOUS ORGANIC REDOX FLOW BATTERIES | U.S. DEPARTMENT OF ENERGY | 2018-04-05 | — | — | US | disclosed |
| US-8142953-B2 | Hydrophilic adjuvant | LG CHEM, LTD. (KR) | 2012-03-27 | — | — | US | disclosed |
| US-20100167168-A1 | Hydrophilic Adjuvant | LG CHEM, LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100167168-A1 | Hydrophilic Adjuvant | CD44, CD74, LY96 | FABP3 625/4885FABP4 121/4885FABP5 569/4885 |
| US-11245111-B2 | Stable positive side material for all-organic flow battery | DUOX1, DUOX2, TST | FABP3 3683/4885FABP4 2928/4885FABP5 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.